It appears GSK and Pfizer — who run a consumer health JV together — forgot to get their story straight ahead of this year’s JP Morgan conference.
On Tuesday, Pfizer chief Albert Bourla said he expected the JV’s majority owner GSK to work toward an IPO within three to four years.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,